Freestone Grove Partners LP Makes New Investment in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
MarketBeat
Freestone Grove Partners LP purchased a new stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 30,313 shares of the biotechnology company's stock, valu
NASDAQ:BCRX